Circunited BioPharma (Shenzhen) Co., Ltd.
Circunited BioPharma (Shenzhen) Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA) | Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, connective tissue disorder, hematologic disorder, hemolytic anemia, immune system disorder, systemic lupus erythematosus | Recruiting | Early phase 1 | 2026-06-05 | NCT07629596 |